Cargando…
Wedelolactone Regulates Lipid Metabolism and Improves Hepatic Steatosis Partly by AMPK Activation and Up-Regulation of Expression of PPARα/LPL and LDLR
Hyperlipidemia is considered one of the greatest risk factors of cardiovascular diseases. We investigated the anti-hyperlipidemic effect and the underlying mechanism of wedelolactone, a plant-derived coumestan, in HepG2 cells and high-fat diet (HFD)−induced hyperlipidemic hamsters. We showed that in...
Autores principales: | Zhao, Yun, Peng, Lu, Yang, Li-chao, Xu, Xu-dong, Li, Wei-jie, Luo, Xiu-mei, Jin, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500417/ https://www.ncbi.nlm.nih.gov/pubmed/26168156 http://dx.doi.org/10.1371/journal.pone.0132720 |
Ejemplares similares
-
Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway
por: Yang, Jin-yu, et al.
Publicado: (2019) -
PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice
por: Garbacz, Wojciech G., et al.
Publicado: (2015) -
Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway
por: Bai, Fan, et al.
Publicado: (2019) -
AMPK-Dependent Metabolic Regulation by PPAR Agonists
por: Lee, Woo Hyung, et al.
Publicado: (2010) -
Erchen Decoction Mitigates Lipid Metabolism Disorder by the Regulation of PPARγ and LPL Gene in a High-Fat Diet C57BL/6 Mice Model
por: Zhang, Mengting, et al.
Publicado: (2020)